Literature DB >> 10880389

Fibrinogen brescia: hepatic endoplasmic reticulum storage and hypofibrinogenemia because of a gamma284 Gly-->Arg mutation.

S O Brennan1, J Wyatt, D Medicina, F Callea, P M George.   

Abstract

The proposita suffered from liver cirrhosis and biopsy showed type 1 membrane-bound fiberglass inclusions. The hepatic inclusion bodies were weakly periodic acid-Schiff diastase-positive, and on immunoperoxidase staining reacted specifically with anti-fibrinogen antisera. Coagulation investigations revealed low functional and antigenic fibrinogen together with a prolonged thrombin time of 37 seconds (normal, 17 to 22 seconds) suggestive of a hypodysfibrinogenemia. DNA sequencing of all three fibrinogen genes showed a single heterozygous mutation of GGG (Gly)-->CGG (Arg) at codon 284 of the gamma-chain gene. However, examination of purified fibrinogen chains by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, reverse-phase high-performance liquid chromatography, ion-exchange high-performance liquid chromatography, and isoelectric focusing, failed to show any evidence of the mutant gamma(Br) chain in plasma fibrinogen. This finding was substantiated by electrospray ionization mass spectrometry, which showed only a normal gamma (and Bbeta) chain mass, but a large increase in the portion of their disialo isoforms. We speculate that misfolding of the variant protein causes hepatic retention and the subsequent hypofibrinogenemia, and that the functional defect (dysfibrinogenemia) results from hypersialylation of otherwise normal Bbeta and gamma chains consequent to the liver cirrhosis. These conclusions were supported by studies on six other family members with hypofibrinogenemia, and essentially normal clotting times, who were heterozygous for the gamma284 Gly-->Arg mutation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10880389      PMCID: PMC1850222          DOI: 10.1016/s0002-9440(10)64530-0

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  26 in total

1.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

Authors:  R K Saiki; D H Gelfand; S Stoffel; S J Scharf; R Higuchi; G T Horn; K B Mullis; H A Erlich
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

2.  Characterization of fibrinogen Milano I: amino acid exchange gamma 330 Asp----Val impairs fibrin polymerization.

Authors:  P Reber; M Furlan; C Rupp; M Kehl; A Henschen; P M Mannucci; E A Beck
Journal:  Blood       Date:  1986-06       Impact factor: 22.113

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Hereditary hypofibrinogenemia with fibrinogen storage in the liver.

Authors:  H Wehinger; O Klinge; E Alexandrakis; J Schürmann; J Witt; H H Seydewitz
Journal:  Eur J Pediatr       Date:  1983-12       Impact factor: 3.183

5.  The separation of globin chains by high pressure cation exchange chromatography.

Authors:  S O Brennan
Journal:  Hemoglobin       Date:  1985       Impact factor: 0.849

Review 6.  Carbohydrate abnormalities of N-linked plasma glycoproteins in liver disease.

Authors:  J Martinéz; C Barsigian
Journal:  Lab Invest       Date:  1987-09       Impact factor: 5.662

7.  Carbohydrate structure of human fibrinogen. Use of 300-MHz 1H-NMR to characterize glycosidase-treated glycopeptides.

Authors:  R R Townsend; E Hilliker; Y T Li; R A Laine; W R Bell; Y C Lee
Journal:  J Biol Chem       Date:  1982-08-25       Impact factor: 5.157

Review 8.  Alpha-1-antitrypsin deficiency.

Authors:  D H Perlmutter
Journal:  Semin Liver Dis       Date:  1998       Impact factor: 6.115

9.  Fibrinogen inclusions in liver cells: a new type of ground-glass hepatocyte. Immune light and electron microscopic characterization.

Authors:  F Callea; R de Vos; R Togni; R Tardanico; M J Vanstapel; V J Desmet
Journal:  Histopathology       Date:  1986-01       Impact factor: 5.087

10.  The role of sialic acid in the dysfibrinogenemia associated with liver disease: distribution of sialic acid on the constituent chains.

Authors:  J Martinez; K A MacDonald; J E Palascak
Journal:  Blood       Date:  1983-06       Impact factor: 22.113

View more
  22 in total

Review 1.  The delicate balance between secreted protein folding and endoplasmic reticulum-associated degradation in human physiology.

Authors:  Christopher J Guerriero; Jeffrey L Brodsky
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

2.  Mutant fibrinogen cleared from the endoplasmic reticulum via endoplasmic reticulum-associated protein degradation and autophagy: an explanation for liver disease.

Authors:  Kristina B Kruse; Amy Dear; Erin R Kaltenbrun; Brandan E Crum; Peter M George; Stephen O Brennan; Ardythe A McCracken
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

3.  Liver glycogen bodies: ground-glass hepatocytes in transplanted patients.

Authors:  Pablo A Bejarano; Monica T Garcia; Maria M Rodriguez; Phillip Ruiz; Andreas G Tzakis
Journal:  Virchows Arch       Date:  2006-09-22       Impact factor: 4.064

Review 4.  Structure and function of factor XI.

Authors:  Jonas Emsley; Paul A McEwan; David Gailani
Journal:  Blood       Date:  2010-01-28       Impact factor: 22.113

Review 5.  Controlling subcellular delivery to optimize therapeutic effect.

Authors:  Mohanad Mossalam; Andrew S Dixon; Carol S Lim
Journal:  Ther Deliv       Date:  2010-07

6.  The fibrous form of intracellular inclusion bodies in recombinant variant fibrinogen-producing cells is specific to the hepatic fibrinogen storage disease-inducible variant fibrinogen.

Authors:  Shinpei Arai; Naoko Ogiwara; Saki Mukai; Yuka Takezawa; Mitsutoshi Sugano; Takayuki Honda; Nobuo Okumura
Journal:  Int J Hematol       Date:  2017-02-04       Impact factor: 2.490

7.  Novel variant fibrinogen γp.C352R produced hypodysfibrinogenemia leading to a bleeding episode and failure of infertility treatment.

Authors:  Masahiro Yoda; Takahiro Kaido; Tomu Kamijo; Chiaki Taira; Yumiko Higuchi; Shinpei Arai; Nobuo Okumura
Journal:  Int J Hematol       Date:  2021-06-12       Impact factor: 2.490

8.  Fibrinogen storage disease without hypofibrinogenemia associated with estrogen therapy.

Authors:  Z Simsek; O Ekinci; M Cindoruk; T Karakan; B Degertekin; G Akyol; S Unal
Journal:  BMC Gastroenterol       Date:  2005-11-15       Impact factor: 3.067

Review 9.  Hepatic and Extrahepatic Sources and Manifestations in Endoplasmic Reticulum Storage Diseases.

Authors:  Francesco Callea; Paola Francalanci; Isabella Giovannoni
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

Review 10.  The Recruitment-Secretory Block ("R-SB") Phenomenon and Endoplasmic Reticulum Storage Diseases.

Authors:  Francesco Callea; Paolo Tomà; Emanuele Bellacchio
Journal:  Int J Mol Sci       Date:  2021-06-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.